Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
View ORCID ProfileYael Gurevich, View ORCID ProfileYoav Ram, View ORCID ProfileLilach Hadany
doi: https://doi.org/10.1101/2021.02.20.21252133
Yael Gurevich
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Yoav Ram
2School of Zoology, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Lilach Hadany
1School of Plant Sciences and Food Security, Faculty of Life Sciences, Tel-Aviv University, Tel-Aviv, 6997801, Israel
Data Availability
The code used to produce the results is available upon request.
Posted February 23, 2021.
Modeling the evolution of SARS-CoV-2 under non-pharmaceutical interventions
Yael Gurevich, Yoav Ram, Lilach Hadany
medRxiv 2021.02.20.21252133; doi: https://doi.org/10.1101/2021.02.20.21252133
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (425)
- Epidemiology (12511)
- Forensic Medicine (10)
- Gastroenterology (798)
- Genetic and Genomic Medicine (4380)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2825)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (892)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4144)
- Nursing (219)
- Nutrition (614)
- Oncology (2183)
- Ophthalmology (620)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (262)
- Palliative Medicine (81)
- Pathology (483)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6730)
- Radiology and Imaging (1479)
- Respiratory Medicine (895)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)